Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials.
about
Human parathyroid hormone for the treatment of osteoporosis in post-menopausal womenPharmacology of the calcium sensing receptorEffects of teriparatide versus alendronate for treatment of postmenopausal osteoporosis: A meta-analysis of randomized controlled trials.Effect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.Statins and hip fracture prevention--a population based cohort study in womenA comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study.Drug delivery interfaces in the 21st century: from science fiction ideas to viable technologies.The calcilytics Calhex-231 and NPS 2143 and the calcimimetic Calindol reduce vascular reactivity via inhibition of voltage-gated Ca2+ channels.Bone health and human immunodeficiency virus infection.A systematic review on the use of daily subcutaneous administration of teriparatide for treatment of patients with osteoporosis at high risk for fracture in Asia.Treatment of osteoporosis: current state of the art.Differential response of MC3T3-E1 and human mesenchymal stem cells to inositol hexakisphosphate.Vitamin D status and bone mineral density changes during alendronate treatment in postmenopausal osteoporosis.
P2860
Q24202763-E1918B00-EE62-41CE-9D1F-50F4649D8973Q26860064-FC688C9F-D313-4843-9BA8-D203F1AD8C93Q33760576-C35F73B3-D09C-455C-8BF1-F74D5FA1EC06Q34149279-23DCFD64-383C-4F3C-8FD4-8E26DE261F1DQ36353931-244428F4-5BD2-4843-A930-D8B4852C1F1BQ37213526-B0341BA7-9DE5-45FD-9501-A1FC856B37ECQ37283351-F344D50A-A784-48C5-A25B-C275227DA101Q37451742-EB795340-4246-4479-BFE5-702D5EB56BACQ38095828-F2BBE6D3-D2C6-4D6D-8DA0-F2856DC6EF13Q38241347-42668CB2-56DE-46BC-804B-8895091004BDQ38287232-022733D0-1F89-4CB9-AB7E-3D38E9AA4BBAQ42828086-EDCE2CEF-ACE0-4417-9775-12231726BB26Q46153653-25FC2581-B1F5-44D3-A88F-EE35E109F0FE
P2860
Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Effect of teriparatide on bone ...... randomised controlled trials.
@ast
Effect of teriparatide on bone ...... randomised controlled trials.
@en
Effect of teriparatide on bone ...... randomised controlled trials.
@nl
type
label
Effect of teriparatide on bone ...... randomised controlled trials.
@ast
Effect of teriparatide on bone ...... randomised controlled trials.
@en
Effect of teriparatide on bone ...... randomised controlled trials.
@nl
prefLabel
Effect of teriparatide on bone ...... randomised controlled trials.
@ast
Effect of teriparatide on bone ...... randomised controlled trials.
@en
Effect of teriparatide on bone ...... randomised controlled trials.
@nl
P2860
P1476
Effect of teriparatide on bone ...... randomised controlled trials.
@en
P2860
P304
P356
10.1111/J.1742-1241.2011.02837.X
P577
2012-02-01T00:00:00Z